DRKS00025086已完成未知
Validation of the incremental therapeutic effect for patients with back pain by using the Movento (traction bed) medical device during nightly sleep
DaThera Consumer Health GmbH0 个研究点目标入组 112 人开始时间: 2021年4月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Osteochondrosis / spondylarthrosis, chronification stage 1 and 2 according to Gerbershagen, age > 40 and < 75 years, weight between 40 and 120 kg, height between 150 and 190 cm, good language skills in the German tongue, legal capacity
排除标准
- •Disability > 50%, stenosis, existing conflict of interest e.g. accident, post-traumatic stress disorder, work related problems e.g.mobbing, depression, psychosis, discitis, myositis, reumatic thrusts, tumor related indications, radicular lumbar syndrom, radicular dorsal syndrom, radicular cervical syndrom, pregnancy, syringomyelia, open wounds, scin infections, dementia, patients with physical disabilities, alcohol or drug usage, scoliosis
研究者
相似试验
已完成
不适用
Evaluation of the treatment efficacy by incrementally increasing dosage of cow's milk on patients with lactose intoleranceactose IntoleranceJPRN-UMIN000023298Tokyo Women's Medical University Medical Center East47
已完成
不适用
Testing the effectiveness of an add-on treatment for impingement syndrome stage I and II - Marnitz therapy as a combination partner for standardized physiotherapy - Pilot StudyImpingement syndrome of shoulderM75.4DRKS00005338Institut für Gesundheits- und PflegewissenschaftMedizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg18
尚未招募
2 期
To study the add on effectiveness of khadira yavagu as food in the management of dadru kushta(tinea)CTRI/2020/11/029372Dr Arsha K S
尚未招募
2 期
To study the add on effectiveness of Palandu peya as a food in the management of Raktapradara(Menorrhagia)CTRI/2020/01/022839Dr Reshma Shaji
进行中（未招募）
2 期
iquid biopsy for treatment guidance in cancerCTRI/2019/02/017548Datar Cancer Genetics Limited